Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colorectal Neoplasms × Fulvestrant × Clear all

Sponsor

Conditions

Breast Neoplasms 93 Neoplasms 12 Neoplasm Metastasis 12 Hereditary Sensory and Autonomic Neuropathies 3 Advanced Breast Cancer 3 Recurrence 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Solid Malignancies 1 Recurrent Uterine Corpus Carcinoma 1 Neoplasms by Site 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Cancer 1 HER2-positive Breast Cancer 1 Exanthema 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Breast Cancer Metastatic 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Bevacizumab 101 Fluorouracil 88 Leucovorin 86 Oxaliplatin 85 Irinotecan 76 Capecitabine 65 Cetuximab 54 Panitumumab 35 pembrolizumab 33 regorafenib 25 Nivolumab 22 Folfox protocol 19 IFL protocol 17 trifluridine tipiracil drug combination 11 durvalumab 11 Radiotherapy 11 Gemcitabine 8 tremelimumab 7 aflibercept 7 Cyclophosphamide 7 Celecoxib 7 binimetinib 6 Sunitinib 6 Drug Therapy 6 Colonoscopy 6 130-nm albumin-bound paclitaxel 6 cediranib 5 Trifluridine 5 Surgical Procedures, Operative 5 Immunoglobulin G 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡